Universitätsklinikum Hamburg-Eppendorf (UKE)

High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels (2019) Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, et al. Conference contribution P53 AND P16 EXPRESSION PROFILES IDENTIFY THREE PROGNOSTICALLY SUBGROUPS IN VULVAR CANCER: A TMA BASED STUDY BY THE AGO-CARE-TRANSLATIONAL STUDY GROUP (2019) Woelber L, Prieske K, Eulenburg C, De Gregorio N, Klapdor R, Kalder M, Braicu I, et al. Conference contribution Response to di Cosimo, Torri, and Porcu (2019) Trapp E, Janni W, Schindlbeck C, Jückstock J, Andergassen U, Degregorio A, Alunni-Fabbroni M, et al. Journal article Ixazomib–Thalidomide–Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma (2019) Ludwig H, Poenisch W, Knop S, Egle A, Schreder M, Lechner D, Hajek R, et al. Journal article Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration) (2019) Kim WK, Schäfer U, Tchetche D, Nef H, Avanzas P, Rudolph T, Scholtz S, et al. Journal article No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study (2019) Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, et al. Journal article Prevention of activated brown adipose tissue in F-18-FDG-PET-imaging in children and adolescents - Which measures are effective? (2019) Poetzsch C, Naumann S, Kurch L, Georgi TW, Weckesser M, Klutmann S, Schmidt D, et al. Conference contribution Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC) (2019) Furlanetto J, Nekljudova V, Schneeweiss A, Thode C, Denkert C, Untch M, Bassy M, et al. Conference contribution PRECYCLE Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy (2019) Degenhardt T, Fasching P, Lueftner D, Mueller V, Thomssen C, Schem C, Witzel I, et al. Conference contribution Delineating the clinical spectrum due to heterozygous TRAF7 missense mutations: A series of 38 cases (2019) Amiel J, Mishra K, Castilla L, Selmer KK, Barak T, Yang S, Blanco-Sanchez B, et al. Conference contribution